| abstract |
The present invention shows a 1-thio-D-glucitol compound represented by the following formula or a pharmaceutically acceptable salt thereof or a hydrate thereof, which shows an activity of inhibiting SGLT2 activity, and an active ingredient thereof. The present invention provides a pharmaceutical composition, especially, a preventive or therapeutic drug for diabetes, diabetes-related diseases or diabetic complications. The present invention also provides a method for producing a 1-thio-D-glucitol compound and an intermediate thereof. [Chemical 1] |